Global Initiative for Chronic Obstructive Lung Disease Global Initiative for Chronic Obstructive Lung Disease
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial - The Lancet Respiratory Medicine
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet
Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment - ScienceDirect
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
Frontiers | Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
Long-term azithromycin increases lumen radius, area in severe persistent asthma
Low-Dose Azithromycin May Improve COPD Exacerbation Outcomes | MedPage Today
PDF) Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
![PDF] Which patients with respiratory disease need long-term azithromycin? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9adeb4fedef4e5128c910a213ee1aa5d77435bfa/2-Table1-1.png "PDF] Which patients with respiratory disease need long-term azithromycin? | Semantic Scholar")
PDF] Which patients with respiratory disease need long-term azithromycin? | Semantic Scholar
Azithromycin for Severe Asthma | Centre of Excellence in Severe Asthma
Azithromycin for Prevention of Exacerbations of COPD | NEJM
Azithromycin in COPD and GERD | Journal of the COPD Foundation
Antibiotic Azithromycin Linked to Death From Cardiovascular Causes | Everyday Health
Which patients with respiratory disease need long-term azithromycin? | Cleveland Clinic Journal of Medicine
Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis - The Lancet Respiratory Medicine
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease | European Respiratory Society
PDF) Role of long-term azithromycin therapy for severe bronchial asthma
Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial - eBioMedicine
![PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/562ad2c017af7c2f6fde4945521ff21cc2c5e818/2-Table1-1.png "PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar")
PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar
What is the evidence for using macrolide antibiotics to treat COVID-19? - The Centre for Evidence-Based Medicine
No more popping pills, now just inhale your antibiotics! | Vadodara News - Times of India
PDF) LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Meta-Analysis of the Adverse Effects of Long-Term Azithromycin Use in Patients with Chronic Lung Diseases | Antimicrobial Agents and Chemotherapy
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease | Thorax
